Air Tamponade Versus Fluorinated Gas Tamponade for Rhegmatogenous Retinal Detachment

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age40+
SponsorLiverpool University Hospitals NHS Foundation Trust

About this trial

TITLE: RCT of air tamponade versus fluorinated gas tamponade for rhegmatogenous retinal detachment DESIGN: Non-inferiority RCT of 150 patients from 10 UK centres AIMS: To assess whether air tamponade is non inferior to gas tamponade for the repair of RRD treated with vitrectomy.

PRIMARY OUTCOME MEASURE: Primary anatomical success with single operation at 24 weeks.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Primary uncomplicated RRD undergoing vitrectomy.

Phakic and pseudophakic eyes

Retinal breaks superiorly between 3 and 9 o'clock, and that are separated by less than 4 clock hours.

Disqualifiers

Absence of PVD

Age 40 years or younger

PVR grade C or above

Aphakia or anterior chamber lens

Trial design

Design model

Parallel

Treatments tested in this trial

  • air

    Procedure/Surgery

    use of sterile air as a tamponade

  • Gas SF6 (Sulfur Hexafluoride) and others

    Procedure/Surgery

    use of fluorinated gases such as SF6, C2F6 or C3F8 as a tamponade agent

Treatment groups

150 Participants
are divided into 2 treatment groups
Group A: Sterile air tamponadeExperimental treatment 1 intervention
Group B: Fluorinated gas tamponadeActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Primary anatomical success

Primary anatomical success at 24 weeks assessed by clinical examination by a retinal surgeon. The Outcome is binary with either 'successful retinal reattachement' or 'failed surgery'

Time frame
6 months

Secondary outcomes

1

Post op visual acuity

Postoperative visual acuity at 10 days, 6 and 24 weeks measured either in Snellen or logMAR

Time frame
10 days, 6 weeks and 24 weeks
2

Intraocular pressure

Day 1, Day 10-, 6- and 24-weeks intraocular pressure measured in mmHg

Time frame
Day 1, 10 and 6 and 24 weeks
3

Quality of Life measures

Generic and vision related quality of life using the Euro quality of Life and Visual function questionnaire at 10 days, 6 and 24 weeks postoperatively. These questionnaires have sections relating to ocular health eg vision, ocular pain etc and impact on daily activities. They create a composite score combining each section, which ranges from 0-100 with higher scores reflecting better vision related quality of life.

Time frame
10 days, 6 and 24 weeks
4

Patient Satisfaction

Patient satisfaction with treatment using the Macular Disease Treatment Satisfaction Questionnaire at 10 days, 6 and 24 weeks. This questionnaire is a self administered questionnaire with a 7 point (0-6) scoring over 14 domains with a total score of 0-72, with higher scores reflecting greater satisfaction

Time frame
10 days, 6 and 24 weeks

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: